These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15269711)

  • 1. Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia.
    Nomura S; Merched A; Nour E; Dieker C; Oka K; Chan L
    Gene Ther; 2004 Oct; 11(20):1540-8. PubMed ID: 15269711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
    Belalcazar LM; Merched A; Carr B; Oka K; Chen KH; Pastore L; Beaudet A; Chan L
    Circulation; 2003 Jun; 107(21):2726-32. PubMed ID: 12742997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade.
    Stein CS; Martins I; Davidson BL
    J Gene Med; 2000; 2(1):41-51. PubMed ID: 10765504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
    Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor.
    Oka K; Pastore L; Kim IH; Merched A; Nomura S; Lee HJ; Merched-Sauvage M; Arden-Riley C; Lee B; Finegold M; Beaudet A; Chan L
    Circulation; 2001 Mar; 103(9):1274-81. PubMed ID: 11238273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of atherogenesis by delivery of TGFbeta1ACT using adeno-associated virus type 2 in LDLR knockout mice.
    Li D; Liu Y; Chen J; Velchala N; Amani F; Nemarkommula A; Chen K; Rayaz H; Zhang D; Liu H; Sinha AK; Romeo F; Hermonat PL; Mehta JL
    Biochem Biophys Res Commun; 2006 Jun; 344(3):701-7. PubMed ID: 16631603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-physiological overexpression of the low density lipoprotein receptor (LDLr) gene in the liver induces pathological intracellular lipid and cholesterol storage.
    Cichon G; Willnow T; Herwig S; Uckert W; Löser P; Schmidt HH; Benhidjeb T; Schlag PM; Schnieders F; Niedzielska D; Heeren J
    J Gene Med; 2004 Feb; 6(2):166-75. PubMed ID: 14978770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor.
    Kobayashi K; Oka K; Forte T; Ishida B; Teng B; Ishimura-Oka K; Nakamuta M; Chan L
    J Biol Chem; 1996 Mar; 271(12):6852-60. PubMed ID: 8636110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice.
    Pastore L; Belalcazar LM; Oka K; Cela R; Lee B; Chan L; Beaudet AL
    Gene; 2004 Mar; 327(2):153-60. PubMed ID: 14980712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice.
    Parks BW; Lusis AJ; Kabarowski JH
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2703-9. PubMed ID: 16990555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfers of vascular endothelial growth factor-A, vascular endothelial growth factor-B, vascular endothelial growth factor-C, and vascular endothelial growth factor-D have no effects on atherosclerosis in hypercholesterolemic low-density lipoprotein-receptor/apolipoprotein B48-deficient mice.
    Leppänen P; Koota S; Kholová I; Koponen J; Fieber C; Eriksson U; Alitalo K; Ylä-Herttuala S
    Circulation; 2005 Aug; 112(9):1347-52. PubMed ID: 16129816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol feeding impedes early atherosclerosis in low-density lipoprotein receptor knockout mice: factors in addition to high-density lipoprotein-apolipoprotein A1 are involved.
    Dai J; Miller BA; Lin RC
    Alcohol Clin Exp Res; 1997 Feb; 21(1):11-8. PubMed ID: 9046367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous gene therapy for familial hypercholesterolemia using ligand-facilitated transfer of a liposome:LDL receptor gene complex.
    Shichiri M; Tanaka A; Hirata Y
    Gene Ther; 2003 May; 10(9):827-31. PubMed ID: 12704424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral low density lipoprotein receptor attenuates progression of atherosclerosis and decreases tissue cholesterol levels in a murine model of familial hypercholesterolemia.
    Jacobs F; Van Craeyveld E; Feng Y; Snoeys J; De Geest B
    Atherosclerosis; 2008 Dec; 201(2):289-97. PubMed ID: 18378244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia.
    Lebherz C; Gao G; Louboutin JP; Millar J; Rader D; Wilson JM
    J Gene Med; 2004 Jun; 6(6):663-72. PubMed ID: 15170737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia.
    Heinonen SE; Leppänen P; Kholová I; Lumivuori H; Häkkinen SK; Bosch F; Laakso M; Ylä-Herttuala S
    Circ Res; 2007 Nov; 101(10):1058-67. PubMed ID: 17872464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic approach to familial hypercholesterolemia by HVJ-liposomes in LDL receptor knockout mouse.
    Tomita N; Morishita R; Koike H; Hashizume M; Notake M; Fujitani B; Kaneda Y; Horiuchi M; Ogihara T
    Int J Mol Med; 2002 Aug; 10(2):137-43. PubMed ID: 12119548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene.
    Kozarsky KF; Jooss K; Donahee M; Strauss JF; Wilson JM
    Nat Genet; 1996 May; 13(1):54-62. PubMed ID: 8673104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for gene therapy of familial hypercholesterolemia.
    Wilson JM; Chowdhury JR
    Mol Biol Med; 1990 Jun; 7(3):223-32. PubMed ID: 2215209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
    Zhao Y; Su B; Jacobs RL; Kennedy B; Francis GA; Waddington E; Brosnan JT; Vance JE; Vance DE
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1349-55. PubMed ID: 19520976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.